Levallorphan tartrate is discontinued (DEA controlled substance). It is an opioid antagonist with properties similar to those of NALOXONE. Levallorphan reverses severe opioid-induced respiratory depression but may exacerbate respiratory depression such as that induced by alcohol or other non-opioid central depressants. References: MILLER JW, GILFOIL TM, SHIDEMAN FE. The effects of levallorphan tartrate (levo-3-hydroxy-N-allylmorphinan tartrate) on the respiration of rabbits given morphine. J Pharmacol Exp Ther. 1955 Nov;115(3):350-9. PubMed PMID: 13272187.

纯度：≥98%

CAS：71-82-9